EXHIBIT 10.12
VIACELL, INC.
13 August 2003
▇▇▇▇▇▇ ▇▇▇▇, MD, PhD.
▇▇ ▇▇▇▇▇ ▇▇
▇▇▇▇▇▇, ▇▇ ▇▇▇▇▇
Dear ▇▇▇▇▇▇:
I would like to thank you for your commitment to being a member of ViaCell,
Inc.'s Medical and Scientific Advisory Board. I look forward to our working
relationship and appreciate your involvement in our company's mission to deliver
the highest quality cellular medicines for the treatment of human disease. This
letter is to conform our agreement effective 1 June 2003. This new agreement is
essentially a one-year extension of our current agreement.
ViaCell will compensate you as outlined below:
- Annual retainer fee of $20,000 paid quarterly in installments of
$5,000
- MSAB meetings generally include dinner meeting night before plus
full day Board meeting.
- Payment to be within 30 days following the attendance:
- $5,000 for attendance to MSAB full day meeting
- $500 for telephonic attendance of MSAB meeting
- Expectation: 2 to 3 MSAB meetings per year. Phone calls,
intermittent consulting, occasional meetings and conference
calls, occasional publication reviews periodically throughout the
year.
- Stock options: 30,000 Non-Qualified Stock Options (12,000 for
role as Chairman and 18,000 for general clinical and scientific
consultant) at $5.00 per share, 9,000 of which are fully vested.
21,000 of the shares will vest on the first annual anniversary
date of this agreement (to represent a one-year commitment).
ViaCell will reimburse you for miscellaneous travel expenses incurred on behalf
of the Company. ▇▇▇ ▇▇▇▇▇▇▇ will arrange your flights and the flight cost will
be billed directly to ViaCell. Other business expenses should be submitted to
▇▇▇ ▇▇▇▇▇▇▇ on the attached expense form. The Company will reimburse you in a
timely fashion. I am confident you will use good prudent business judgment as it
relates to business travel expenses.
VIACELL, INC.O ▇▇▇ ▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇ ▇▇▇▇▇▇, ▇▇▇▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇
PHONE 617 266 4373O FAX 617 247 4733O ▇▇▇.▇▇▇▇▇▇▇▇▇▇.▇▇▇
May 27, 2003
▇▇▇▇▇▇ ▇▇▇▇▇, MD, PhD.
Page 2 of 2
This agreement may be terminated after twelve months by either party upon 14
days written notice for any reason or immediately in the event of a breach of
the terms of any agreement between the parties. It is further understood that
while you are serving as a member of ▇▇▇▇▇▇▇'s Medical and Scientific Advisory
Board, you will not serve as a consultant, employee, or in any similar capacity
with any entity or individual in competition with ViaCell, Inc. and its Viacord
Cord Blood Banking Service.
A copy of this agreement letter and ▇▇▇▇▇▇▇'s Non-Disclosure Agreement are
enclosed for your signature. One set of copies is for you and the other to
return to us in the self-addressed envelope.
Sincerely,
/s/ ▇▇▇▇ ▇▇▇▇
▇▇▇▇ ▇. ▇▇▇▇
Chairman and Chief Executive Officer Agreed to by:
/s/ ▇▇▇▇▇▇ ▇▇▇▇▇
----------------------------
▇▇▇▇▇▇ ▇▇▇▇▇, MD, PhD.
